The effect of a new tetracyclic anti-depressant compound, Org GB 94, on the turnover of dopamine, noradrenalin and serotonin in the rat brain.
D000639:Amitriptyline / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002250:Carbon Radioisotopes; D003984:Dibenzazepines / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism*; D007099:Imipramine / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009638:Norepinephrine / Q000378:metabolism*; D011719:Pyrazines / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000378:metabolism*; D013268:Stimulation, Chemical; D013997:Time Factors; D014316:Tritium; D014364:Tryptophan / Q000378:metabolism; D014439:Tyramine / Q000378:metabolism; D014443:Tyrosine / Q000378:metabolism
D000928:Antidepressive Agents; D002250:Carbon Radioisotopes; D003984:Dibenzazepines; D011719:Pyrazines; D014316:Tritium; D000639:Amitriptyline; D012701:Serotonin; D014443:Tyrosine; D014364:Tryptophan; D007099:Imipramine; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine